Área salud
Comparative study of infusion-related reactions to anti-CD20 drugs in neuroimmunological diseases of the central nervous system: a retrospective analysis of ocrelizumab and rituximab treatments
Introduction The anti-CD20 monoclonal antibodies, rituximab (RTX) and ocrelizumab (OCRE), are used routinely for the treatment of neuroimmunological diseases. However, infusion-related reactions (IRRs) are common, and their underlying mechanisms are not well defined. Objectives Our […]
Área salud
Experience With Rituximab in Patients With Pemphigus Vulgaris and Hepatitis B
Rituximab is an anti-CD20 monoclonal antibody used as first-line therapy for moderate-to-severe pemphigus vulgaris. For many years, it was contraindicated in patients with a past medical history of hepatitis B due to the risk of […]